Clinical Trial

ECMO ABI Detection With Hyperfine

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.
Protocol Amendment History 1 change
notable Enrollment increased: 30 -> 40 participants 2026-08-12
Trial Details
NCT Number NCT06469801
Lead Sponsor Children's Mercy Hospital Kansas City
Conditions Acute Brain Injury, Extracorporeal Membrane Oxygenation Complication, Hypoxia-Ischemia, Brain, Stroke, Acute
Enrollment 40 participants
Start Date 2024-07-23
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11